
Text of Senate Amendment 850 Congressional Record, Volume 171 Issue 34 (Thursday, February 20, 2025) [Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)] [Senate] [Pages S1249-S1250] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] SA 850. Ms. ROSEN submitted an amendment intended to be proposed by her to the concurrent resolution S. Con. Res. 7, setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; which was ordered to lie on the table; as follows: At the appropriate place in title IV, add the following: [[Page S1250]] SEC. 4___. POINT OF ORDER AGAINST LEGISLATION THAT WOULD INCREASE THE COST OF PRESCRIPTION DRUGS, INCLUDING $35 INSULIN, INCREASE OUT-OF-POCKET COSTS FOR MEDICARE BENEFICIARIES, OR INCREASE DRUG COSTS FOR PATIENTS ON MEDICAID, WITH PRIVATE HEALTH INSURANCE, ON TRICARE, OR WHO ARE UNINSURED. (a) Point of Order.--It shall not be in order in the Senate to consider any bill, joint resolution, motion, amendment, amendment between the Houses, or conference report that would increase the cost of prescription drugs, including $35 insulin, increase out-of-pocket costs for Medicare beneficiaries, or increase drug costs for patients on Medicaid, with private health insurance, on TRICARE, or who are uninsured. (b) Waiver and Appeal.--Subsection (a) may be waived or suspended in the Senate only by an affirmative vote of three- fifths of the Members, duly chosen and sworn. An affirmative vote of three-fifths of the Members of the Senate, duly chosen and sworn, shall be required to sustain an appeal of the ruling of the Chair on a point of order raised under subsection (a). ______